华康生物医学(08622.HK)：擎天资本获委任为独立财务顾问

Group 1 - The core announcement is that Huakang Biomedical (08622.HK) has appointed Qingtian Capital Limited as an independent financial advisor to provide advice on the offer and acceptance situation to the independent board committee, offer shareholders, and option holders [1][2] - The appointment of Qingtian Capital has been approved by the independent board committee in accordance with the takeover code rule 2.1 [1] - Huakang Biomedical has resumed trading this morning following the announcement [2]